BANK VONTOBEL/CALL/DANAHER/270/0.1/20.12.24 Stock

Warrant

DE000VD3R2F7

Market Closed - Boerse Frankfurt Warrants 13:56:32 2024-07-05 EDT
0.69 EUR -2.82% Intraday chart for BANK VONTOBEL/CALL/DANAHER/270/0.1/20.12.24
Current month-37.84%
1 month-65.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-05 0.69 -2.82%
24-07-04 0.71 -2.74%
24-07-03 0.73 -2.67%
24-07-02 0.75 -14.77%
24-07-01 0.88 -20.72%

Real-time Boerse Frankfurt Warrants

Last update July 05, 2024 at 01:56 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying DANAHER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VD3R2F
ISINDE000VD3R2F7
Date issued 2024-04-09
Strike 270 $
Maturity 2024-12-20 (167 Days)
Parity 10 : 1
Emission price 1.28
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.05
Lowest since issue 0.67
Delta0.32x
Omega 9.864
Premium16.05x
Gearing31.31x
Moneyness 0.8861
Difference Strike 30.75 $
Difference Strike %+11.39%
Spread 0.01
Spread %1.41%
Theoretical value 0.7050
Implied Volatility 25.26 %
Total Loss Probability 74.28 %
Intrinsic value 0.000000
Present value 0.7050
Break even 277.64 €
Theta-0.03x
Vega0.05x
Rho0.03x

Company Profile

Danaher Corporation is an industrial and technologic group organized around two families of products: - medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.; - professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc. Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Sector
-
More about the company

Ratings for Danaher Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Danaher Corporation

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
239.2 USD
Average target price
274.8 USD
Spread / Average Target
+14.86%
Consensus